NPCE - NeuroPace 10% Owner Trades $75K In Company Stock | Benzinga
ORBIMED ADVISORS LLC, 10% Owner at NeuroPace (NASDAQ:NPCE), reported a large insider sell on October 4, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that LLC sold 8,314 shares of NeuroPace. The total transaction amounted to $75,449.
NeuroPace shares are trading up 13.38% at $8.9 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing decision, however an ...